DocuSign (DOCU) is back in focus after a busy early September, with the stock reacting to a mix of stronger than expected second quarter results, raised guidance, and fresh AI driven product and partnership announcements.
Over the past quarter, DocuSign’s share price return of 39.6% and 30 day share price return of 14.7% point to strengthening momentum, even though the one year total shareholder return has declined 13.5% and the five year total shareholder return is down 76.6%. This indicates that the recent enthusiasm is emerging from a still depressed longer term base.
Use DocuSign’s recent AI driven momentum as a starting point and scan a curated short list of 71 profitable AI stocks that aren't just burning cash.
The bounce in DocuSign is sharp and rooted in real news on earnings and AI products. After such a quick move off a long term slump, investors may question whether the current valuation still leaves enough potential reward to justify the risk.
DocuSign last closed at $65.97 while the most followed narrative, according to rcb9, places fair value closer to $60.99. That gap frames the current debate over whether the recent AI enthusiasm has moved the stock ahead of its underlying assumptions.
On a market capitalisation basis, justifying roughly $11.0 billion at a 9% discount needs about $850 million of GAAP net income in 2031, which on 7% revenue growth implies a net margin near 19%.
The buyback lowers that materially, because the same earnings are spread across fewer shares. Once you run the inputs and I can solve the constant, I will pin the exact requirement. My provisional read is that at the current repurchase pace the requirement falls to roughly 15%, which is close to the base case, meaning DocuSign is priced near fair on these assumptions rather than obviously cheap or dear.
Want to see what sits behind that tight gap between price and fair value? The narrative leans on steady growth, higher margins over time, and a richer earnings multiple. It also puts real weight on how aggressively DocuSign shrinks its share count. It is worth considering which of those levers does most of the heavy lifting in this model.
Result: Fair Value of $60.99 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, DocuSign’s story can change quickly if IAM stalls below targets or if share based compensation keeps pressure on GAAP margins and limits the real impact of buybacks.
Find out about the key risks to this DocuSign narrative.
The community narrative pegs DocuSign as about 8.2% overvalued at $65.97 compared to a $60.99 fair value. Our DCF model offers a very different take. It estimates future cash flows at about $148.82 per share, which points to the stock trading well below that level.
That gap between a cash flow based estimate and a more conservative earnings based narrative raises a key question for you. Which set of assumptions about growth, margins, and buybacks feels more realistic over time, and how much weight should each view carry in your own work.
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out DocuSign for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 52 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
With sentiment on DocuSign clearly split between risk and reward, take a moment to move fast and weigh the trade off yourself with the 2 key rewards and 1 important warning sign
Do not stop with DocuSign. Use the Simply Wall Street Screener to quickly surface fresh ideas that fit your style before the crowd focuses on them.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com